RELATED PARTY TRANSACTIONS (Details) - USD ($)		9 Months Ended		12 Months Ended
		Dec. 31, 2019	Dec. 31, 2018	Mar. 31, 2019
Related Party Transactions [Abstract]
Liability due to related party, beginning of period		$ 964,679	$ 613,818	$ 613,818
Amounts invoiced by DDL to Pharma		(5,874)	0	(977)
Amount invoiced by Pharma to DDL, NM and TCL	[1]	1,369,272	1,539,114	2,312,412
Amounts repaid by DDL to Pharma		(1,642,019)	(1,130,755)	(1,569,496)
Amounts invoiced by B&W to DDL		0	0	2,206
Amounts repaid by DDL to B&W		0	0	(5,622)
Foreign exchange differences		15,970	(103,383)	(84,843)
Forgiveness of payable accounted for as equity contribution		0	0	(302,819)
Liability due to related party, end of the period		$ 702,028	$ 918,794	$ 964,679

[1] These amounts are included primarily in research and development expenses charged to the Company by Pharma.